Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences , 381 Royal Parade, Parkville, VIC 3052, Australia.
Department of Pharmacy, Uppsala Biomedical Centre, Uppsala University , P.O. Box 580, SE-751 23 Uppsala, Sweden.
J Phys Chem B. 2017 Dec 7;121(48):10869-10881. doi: 10.1021/acs.jpcb.7b08622. Epub 2017 Nov 21.
The absorption of hydrophobic drugs and nutrients from the intestine is principally determined by the amount that can be dissolved by the endogenous fluids present in the gut. Human intestinal fluids (HIFs) comprise a complex mixture of bile salts, phospholipids, steroids and glycerides that vary in composition in the fed and fasted state and between subjects. A number of simulated intestinal fluid (SIF) compositions have been developed to mimic fasted and fed state intestinal conditions and allow the in vitro determination of drug solubility as a proxy for the maximum dissolved concentration it is possible to reach. In particular these solvents are used during the development of lipophilic and poorly water-soluble drugs but questions remain around the differences that may arise from the source and methods of preparation of these fluids. In this work, a range of SIFs were studied using small-angle X-ray scattering (SAXS), cryogenic-transmission electron microscopy (cryo-TEM) and molecular dynamics (MD) simulations in order to analyze their structures. In-house prepared SIFs based on sodium taurodeoxycholate (NaTDC) and 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) formed oblate ellipsoidal micelles irrespective of lipid concentration and preparation conditions. In contrast, commercially available SIFs based on sodium taurocholate and lecithin formed prolate ellipsoidal micelles in the fed state and vesicles in the fasted state. These structural variations are the likely reason for the dramatic differences sometimes observed in the solubility enhancements for hydrophobic drugs, nutrients and digestion products when using different SIFs. However, the structural homogeneity of the NaTDC/DOPC micelles makes them ideal candidates for standardizing SIF formulations as the structures of the solubilizing nanoaggregates therein are not sensitive to the preparation method.
疏水药物和营养素从肠道的吸收主要取决于可被肠道中存在的内源性液体溶解的量。人肠液(HIF)由胆盐、磷脂、类固醇和甘油酯组成,其组成在进食和禁食状态以及个体之间存在差异。已经开发了许多模拟肠液(SIF)组合物来模拟进食和禁食状态下的肠道条件,并允许体外测定药物溶解度,作为达到最大溶解浓度的替代指标。特别是这些溶剂在亲脂性和低水溶性药物的开发中使用,但仍存在一些问题,例如这些流体的来源和制备方法可能存在差异。在这项工作中,使用小角 X 射线散射(SAXS)、低温透射电子显微镜(cryo-TEM)和分子动力学(MD)模拟研究了一系列 SIF,以分析它们的结构。基于牛磺脱氧胆酸钠(NaTDC)和 1,2-二油酰基-sn-甘油-3-磷酸胆碱(DOPC)的自制 SIF 形成扁长椭圆型胶束,与脂质浓度和制备条件无关。相比之下,基于牛胆酸钠和卵磷脂的市售 SIF 在进食状态下形成长椭圆型胶束,在禁食状态下形成囊泡。这些结构变化可能是使用不同 SIF 时有时观察到疏水性药物、营养素和消化产物溶解度增强的显著差异的原因。然而,NaTDC/DOPC 胶束的结构均一性使它们成为标准化 SIF 配方的理想候选物,因为其中的增溶纳米聚集体的结构不受制备方法的影响。